Diagnosis, monitoring, and management of axial spondyloarthritis
Rheumatology International · 17.05.2024 · 44 (8) · 1395-1407
DOI: 10.1007/s00296-024-05615-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Rheumatology International, online erschienen am 17.05.2024. Verfasst von Olena Zimba und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Krakow, Krakow, Poland. Hauptthemen laut MEDLINE: Axial Spondyloarthritis, Antirheumatic Agents. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Badań i Rozwoju.
Abstract (Originalsprache)
Axial spondyloarthritis (axSpA) is a chronic condition predominantly affecting the spine and sacroiliac joints. This article provides an in-depth overview of the current approaches to diagnosing, monitoring, and managing axSpA, including insights into developing terminology and diagnostic difficulties. A substantial portion of the debate focuses on the challenging diagnostic procedure, noting the difficulty of detecting axSpA early, particularly before the appearance of radiologic structural changes. Despite normal laboratory parameters, more than half of axSpA patients experience symptoms. X-ray and magnetic resonance imaging (MRI) are essential for evaluating structural damage and inflammation. MRI can be beneficial when there is no visible structural damage on X-ray as it can help unravel bone marrow edema (BME) as a sign of ongoing inflammation. The management covers both non-pharmacological and pharmacological approaches. Lifestyle modifications, physical activity, and patient education are essential components of the management. Pharmacological therapy, including nonsteroidal anti-inflammatory drugs (NSAIDs) and biologic disease-modifying anti-rheumatic drugs (bDMARDs), are explored, emphasizing individualized treatment. To effectively manage axSpA, a comprehensive and well-coordinated approach is necessary, emphasizing the significance of a multidisciplinary team. Telehealth applications play a growing role in axSpA management, notably in reducing diagnostic delays and facilitating remote monitoring. In conclusion, this article underlines diagnostic complexities and emphasizes the changing strategy of axSpA treatment. The nuanced understanding offered here is designed to guide clinicians, researchers, and healthcare providers toward a more comprehensive approach to axSpA diagnosis and care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Krakow, Krakow, Poland.
- National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
- Department of Internal Medicine N2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
- Department of Physical Medicine and Rehabilitation, University of Health Sciences, Adana City Research and Training Hospital, Adana, Türkiye.
- Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Krakow, Krakow, Poland. mariusz.korkosz@uj.edu.pl.
- Department of Rheumatology and Immunology, Jagiellonian University Medical College, Jakubowskiego 2 Str., 30-688, Kraków, Poland. mariusz.korkosz@uj.edu.pl.
ORCID-Profile: Olena Zimba, Burhan Fatih Kocyigit, Mariusz Korkosz
Förderung
- Narodowe Centrum Badań i Rozwoju
Zitieren
APA
Zimba, O., Kocyigit, B. F., & Korkosz, M. (2024). Diagnosis, monitoring, and management of axial spondyloarthritis. Rheumatology International, 44(8), 1395-1407. https://doi.org/10.1007/s00296-024-05615-3
Vancouver
Zimba O, Kocyigit BF, Korkosz M. Diagnosis, monitoring, and management of axial spondyloarthritis. Rheumatology International. 2024;44(8):1395-1407. doi:10.1007/s00296-024-05615-3
BibTeX
@article{Zimba2024,
author = {Zimba, Olena and Kocyigit, Burhan Fatih and Korkosz, Mariusz},
title = {Diagnosis, monitoring, and management of axial spondyloarthritis},
journal = {Rheumatology International},
year = {2024},
volume = {44},
number = {8},
pages = {1395--1407},
doi = {10.1007/s00296-024-05615-3}
}
EUVIMED